v3.26.1
Segment Information (Tables)
 6 Months Ended
Jun. 30, 2026
Segment Reporting [Abstract]  
Schedule of Business Segments
Engineered
Materials		Acetyl ChainOther
Activities		EliminationsConsolidated
(In $ millions)
Three Months Ended June 30, 2026
Net sales1,446 1,329 — (23)(1)2,752 
Cost of sales(1,129)(1,032)4 23 (2,134)
Gross profit317 297 4 — 618 
Selling, general and administrative expenses(94)(30)(127)— (251)
Amortization of intangible assets(39)— — — (39)
Research and development expenses(19)(9)(1)— (29)
Other (charges) gains, net (Note 18)
(8)(21)(2)— (31)
Gain (loss) on disposition of business and assets, net(1)— (1)— (2)
Other segment items(2)
— — 10 — 10 
Operating profit (loss)156 237 (117)— 276 
Depreciation and amortization
144 86 14 — 244 
Equity in net earnings (loss) of affiliates
6 1 4 — 11 
Capital expenditures36 29 2 — 67 (3)
Three Months Ended June 30, 2025
Net sales1,442 1,115 — (25)(1)2,532 
Cost of sales(1,098)(925)— 25 (1,998)
Gross profit344 190 — — 534 
Selling, general and administrative expenses(101)(23)(90)— (214)
Amortization of intangible assets(41)(1)— — (42)
Research and development expenses(20)(11)— — (31)
Other (charges) gains, net (Note 18)
(16)(1)(3)— (20)
Gain (loss) on disposition of business and assets, net(2)(1)1 — (2)
Other segment items(2)
— — 6 — 6 
Operating profit (loss)164 153 (86)— 231 
Depreciation and amortization
114 64 12 — 190 
Equity in net earnings (loss) of affiliates
24 2 3 — 29 
Capital expenditures46 32 6 — 84 (3)
______________________________
(1)Includes intersegment sales primarily related to the Acetyl Chain.
(2)Includes Foreign exchange gain (loss), net.
(3)Includes an increase in accrued capital expenditures of $5 million and a decrease of $9 million for the three months ended June 30, 2026 and 2025, respectively.
Engineered
Materials		Acetyl ChainOther
Activities		EliminationsConsolidated
(In $ millions)
Six Months Ended June 30, 2026
Net sales2,771 2,365 — (47)(1)5,089 
Cost of sales(2,122)(1,927)(1)47 (4,003)
Gross profit649 438 (1)— 1,086 
Selling, general and administrative expenses(189)(56)(232)— (477)
Amortization of intangible assets(78)(1)— — (79)
Research and development expenses(37)(19)(1)— (57)
Other (charges) gains, net (Note 18)
(15)(30)(6)— (51)
Gain (loss) on disposition of business and assets, net47 — (1)— 46 
Other segment items(2)
— — 22 — 22 
Operating profit (loss)377 332 (219)— 490 
Depreciation and amortization
251 167 27 — 445 
Equity in net earnings (loss) of affiliates
37 3 6 — 46 
Capital expenditures59 49 3 — 111 (3)
As of June 30, 2026
Goodwill and intangible assets, net6,796 430 — — 7,226 
Total assets13,534 5,382 2,492 — 21,408 
Six Months Ended June 30, 2025
Net sales2,729 2,231 — (39)(1)4,921 
Cost of sales(2,111)(1,840)(1)39 (3,913)
Gross profit618 391 (1)— 1,008 
Selling, general and administrative expenses(208)(51)(186)— (445)
Amortization of intangible assets(81)(1)— — (82)
Research and development expenses(42)(20)— — (62)
Other (charges) gains, net (Note 18)
(31)(4)(16)— (51)
Gain (loss) on disposition of business and assets, net2 (1)— — 1 
Other segment items(2)
— — 27 — 27 
Operating profit (loss)258 314 (176)— 396 
Depreciation and amortization
223 125 22 — 370 
Equity in net earnings (loss) of affiliates
40 5 6 — 51 
Capital expenditures85 62 15 — 162 (3)
As of December 31, 2025
Goodwill and intangible assets, net
6,917 438 — — 7,355 
Total assets13,971 5,3022,422 — 21,695 
______________________________
(1)Includes intersegment sales primarily related to the Acetyl Chain.
(2)Includes Foreign exchange gain (loss), net.
(3)Includes a decrease in accrued capital expenditures of $17 million and $33 million for the six months ended June 30, 2026 and 2025, respectively.